Drug recall unlikely to pinch Ranbaxy
473527
Ranbaxy&#39;s decision to pull its AIDS drugs off the World Health Organisation list will have little impact on the Indian firm because they form only a small part of its portfolio, analysts said on Wednesday.
415386
The recall of Merck&#39;s arthritis drug Vioxx has drawn attention to drug overall safety, more specifically, a similar drug known as Celebrex, by the drug maker Pfizer.
697522
If its latest drug isn't approved, the pharmaceutical could face trouble.
721599
The recall of a routine vaccine for babies due to contamination risks could trigger a shortage and likely will alarm parents, but officials said there is no known health threat.
392614
Amidst recent prescription drug recalls, health experts have tips for patients to determine the safety of their medications. Merck Pharmaceuticals&#39; September decision to withdraw its widely used arthritis
470170
Geneva: India&#39;s top pharmaceutical group Ranbaxy has withdrawn all its anti-retroviral drugs from a World Health Organisation scheme setting minimum quality standards for cheaper anti-AIDS medication aimed at poor countries, the WHO said Tuesday.
633786
A pharmaceutical company issued a nationwide recall yesterday of about 500 bottles of a drug used to treat attention-deficit hyperactivity disorder and narcolepsy.
387905
The beleaguered drug giant&#39;s lowered forecast isn&#39;t as bad as Wall Street expected. But investors still await the long-term prognosis.
619694
ASTRAZENECAâS anti-clotting drug Exanta is unlikely to win US approval in the near future, the company said as it revealed a delay with another new drug, Galida for diabetes.
310955
HIV drug Viracept has been recalled because "human error" led to a higher than normal level of a chemical which can cause cancer.  (c) 2007 Liverpool Echo. Provided by ProQuest Information and Learning.
602837
A drug used to prevent excessive bleeding during bypass surgery should remain on the market despite being linked to increased risk of death and other serious side effects, federal advisers recommended Wednesday.
704522
Unwanted phase 2 results might not scuttle a promising hepatitis C drug.
131978
Some analysts are betting Pfizer Inc.  won't have to withdraw its arthritis drug Celebrex but they do expect sales to fall after a study of the drug in cancer patients showed it increased the risk of heart attacks.
241801
An Indian pharmaceutical company, Ranbaxy, has withdrawn of ten of its generic AIDS drugs after an investigation revealed flaws in research claiming the drugs were as effective as patented ones.
311263
Boston Scientific Corp. BSX.N, whose  Taxus heart device has been involved in a major recall, said on  Wednesday preliminary August sales of the device slowed to $200  million from $207 million reported in July, and issued an  outlook that was below Wall Street estimates.
550945
The catheter that triggered three safety recalls by Boston Scientific Corp. of its best-selling Taxus coronary stent after being linked to three deaths and 47 injuries had not been subjected to the rigors of a human clinical trial, FDA records show.
406746
The recall of a routine vaccine for babies due to contamination risks could trigger a shortage and likely will alarm parents, but officials said there is no known health threat